Clinical impact of amyloid PET using 18F-florbetapir in patients with cognitive impairment and suspected Alzheimer’s disease: a multicenter study

被引：0

作者：

Hiroshi Matsuda

Kyoji Okita

Yumiko Motoi

Toshiki Mizuno

Manabu Ikeda

Nobuo Sanjo

Koji Murakami

Taiki Kambe

Toshiki Takayama

Kei Yamada

Takashi Suehiro

Keiko Matsunaga

Takanori Yokota

Ukihide Tateishi

Yoko Shigemoto

Yukio Kimura

Emiko Chiba

Takahiro Kawashima

Yui Tomo

Hisateru Tachimori

Yuichi Kimura

Noriko Sato

机构：

[1] National Center of Neurology and Psychiatry,Department of Radiology

[2] Fukushima Medical University,Department of Biofunctional Imaging

[3] Southern Tohoku Research Institute for Neuroscience,Drug Discovery and Cyclotron Research Center

[4] National Center of Neurology and Psychiatry,Integrative Bain Imaging Center

[5] Juntendo University Graduate School of Medicine,Department of Diagnosis, Prevention, and Treatment of Dementia

[6] Kyoto Prefectural University of Medicine,Department of Neurology

[7] Osaka University Graduate School of Medicine,Department of Psychiatry

[8] Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences,Department of Neurology and Neurological Science

[9] Juntendo University Graduate School of Medicine,Department of Radiology

[10] Juntendo University Graduate School of Medicine,Department of Neurology

[11] Juntendo University Graduate School of Medicine,Department of Psychiatry

[12] Kyoto Prefectural University of Medicine,Department of Radiology

[13] Osaka University Graduate School of Medicine,Department of Molecular Imaging in Medicine

[14] Tokyo Medical and Dental University Graduate School of Medical and Dental Sciences,Department of Diagnostic Radiology

[15] Department of Clinical Data Science,Faculty of Informatics

[16] Clinical Research & Education Promotion Division,undefined

[17] National Center of Neurology and Psychiatry,undefined

[18] Cyber Informatics Research Institute,undefined

来源：

Annals of Nuclear Medicine | 2022年 / 36卷

关键词：

Alzheimer’s disease; Amyloid; PET; F-florbetapir;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

页码：1039 / 1049

页数：10

共 174 条

[21]

Grundman M(1975)C-PiB PET amyloid images of the Japanese Alzheimer’s disease neuroimaging Initiative (J-ADNI) multicenter study J Psychiatr Res 12 189-35

[22]

Pontecorvo MJ(2011)Use of standardized uptake value ratios decreases interreader variability of [ Alzheimers Dement 7 263-631

[23]

Salloway SP(2016)F] florbetapir PET brain scan interpretation EJNMMI Phys 3 23-216

[24]

Doraiswamy PM(2022)The Centiloid project: standardizing quantitative amyloid plaque estimation by PET Brain Behav 12 e2499-678

[25]

Fleisher AS(1950)Standardization of amyloid quantitation with florbetapir standardized uptake value ratios to the centiloid scale Cancer 3 32-969

[26]

Sadowsky CH(2012)“Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician Eur J Nucl Med Mol Imaging 39 621-2446

[27]

Mitsis EM(2019)The diagnosis of dementia due to Alzheimer’s disease: recommendations from the National Institute on Aging-Alzheimer’s Association workgroups on diagnostic guidelines for Alzheimer’s disease Alzheimers Dement 15 205-undefined

[28]

Bender HA(2020)Phantom criteria for qualification of brain FDG and amyloid PET across different cameras Alzheimers Res Ther 12 22-undefined

[29]

Kostakoglu L(2012)Software development for quantitative analysis of brain amyloid PET Lancet Neurol 11 669-undefined

[30]

Machac J(2021)Index for rating diagnostic tests Alzheimers Res Ther 13 99-undefined

← 1 2 3 4 5 6 7 8 9 10 →